Cargando…

Comparative performance of a panel of commercially available antimicrobial nanocoatings in Europe

BACKGROUND: Bacterial resistance against the classic antibiotics is posing an increasing challenge for the prevention and treatment of infections in health care environments. The introduction of antimicrobial nanocoatings with active ingredients provides alternative measures for active killing of mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Molling, Johan W, Seezink, Jacques W, Teunissen, Birgit EJ, Muijrers-Chen, Inhua, Borm, Paul JA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230231/
https://www.ncbi.nlm.nih.gov/pubmed/25404853
http://dx.doi.org/10.2147/NSA.S70782
_version_ 1782344232423391232
author Molling, Johan W
Seezink, Jacques W
Teunissen, Birgit EJ
Muijrers-Chen, Inhua
Borm, Paul JA
author_facet Molling, Johan W
Seezink, Jacques W
Teunissen, Birgit EJ
Muijrers-Chen, Inhua
Borm, Paul JA
author_sort Molling, Johan W
collection PubMed
description BACKGROUND: Bacterial resistance against the classic antibiotics is posing an increasing challenge for the prevention and treatment of infections in health care environments. The introduction of antimicrobial nanocoatings with active ingredients provides alternative measures for active killing of microorganisms, through a preventive hygiene approach. PURPOSE: The purpose of this study was to investigate the antimicrobial activity of a panel of antimicrobial coatings available on the European market. METHODS: A comparative, biased selection of commercially available antimicrobial coatings was tested for antimicrobial efficiency. Suppliers were contacted to deliver their coatings on glass and/or stainless steel substrates. In total, 23 coatings from eleven suppliers were received, which were investigated for their effect on the growth of Escherichia coli, using the International Organization for Standardization (ISO) 22196 protocol. RESULTS: The majority of nanomaterial-containing coatings (n=13) contained nanosilver (n=12), while only one had photocatalytic TiO(2) as the active particle. The differences in antimicrobial activity among all of the coatings, expressed as log reduction values, varied between 1.3 and 6.6, while the variation within the nanomaterial-based group was between 2.0 and 6.2. Although nanosilver coatings were on average very effective in reducing the number of viable bacteria after challenge, the strongest log reduction (6.6) was seen with a coating that has immobilized, covalently bound quaternary ammonium salt in its matrix. Besides these two compounds, coatings containing TiO(2), poly(dimethylsiloxane), triclosan, or zinc pyrithione evoked 100% killing of E. coli. CONCLUSION: Our findings indicate that nanosilver dominates the nanoparticle-based coatings and performs adequately. However, considering the unknowns in relation to ecotoxicological emission and effects, it needs further consideration before widespread application into different environments.
format Online
Article
Text
id pubmed-4230231
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-42302312014-11-17 Comparative performance of a panel of commercially available antimicrobial nanocoatings in Europe Molling, Johan W Seezink, Jacques W Teunissen, Birgit EJ Muijrers-Chen, Inhua Borm, Paul JA Nanotechnol Sci Appl Original Research BACKGROUND: Bacterial resistance against the classic antibiotics is posing an increasing challenge for the prevention and treatment of infections in health care environments. The introduction of antimicrobial nanocoatings with active ingredients provides alternative measures for active killing of microorganisms, through a preventive hygiene approach. PURPOSE: The purpose of this study was to investigate the antimicrobial activity of a panel of antimicrobial coatings available on the European market. METHODS: A comparative, biased selection of commercially available antimicrobial coatings was tested for antimicrobial efficiency. Suppliers were contacted to deliver their coatings on glass and/or stainless steel substrates. In total, 23 coatings from eleven suppliers were received, which were investigated for their effect on the growth of Escherichia coli, using the International Organization for Standardization (ISO) 22196 protocol. RESULTS: The majority of nanomaterial-containing coatings (n=13) contained nanosilver (n=12), while only one had photocatalytic TiO(2) as the active particle. The differences in antimicrobial activity among all of the coatings, expressed as log reduction values, varied between 1.3 and 6.6, while the variation within the nanomaterial-based group was between 2.0 and 6.2. Although nanosilver coatings were on average very effective in reducing the number of viable bacteria after challenge, the strongest log reduction (6.6) was seen with a coating that has immobilized, covalently bound quaternary ammonium salt in its matrix. Besides these two compounds, coatings containing TiO(2), poly(dimethylsiloxane), triclosan, or zinc pyrithione evoked 100% killing of E. coli. CONCLUSION: Our findings indicate that nanosilver dominates the nanoparticle-based coatings and performs adequately. However, considering the unknowns in relation to ecotoxicological emission and effects, it needs further consideration before widespread application into different environments. Dove Medical Press 2014-11-07 /pmc/articles/PMC4230231/ /pubmed/25404853 http://dx.doi.org/10.2147/NSA.S70782 Text en © 2014 Molling et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Molling, Johan W
Seezink, Jacques W
Teunissen, Birgit EJ
Muijrers-Chen, Inhua
Borm, Paul JA
Comparative performance of a panel of commercially available antimicrobial nanocoatings in Europe
title Comparative performance of a panel of commercially available antimicrobial nanocoatings in Europe
title_full Comparative performance of a panel of commercially available antimicrobial nanocoatings in Europe
title_fullStr Comparative performance of a panel of commercially available antimicrobial nanocoatings in Europe
title_full_unstemmed Comparative performance of a panel of commercially available antimicrobial nanocoatings in Europe
title_short Comparative performance of a panel of commercially available antimicrobial nanocoatings in Europe
title_sort comparative performance of a panel of commercially available antimicrobial nanocoatings in europe
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230231/
https://www.ncbi.nlm.nih.gov/pubmed/25404853
http://dx.doi.org/10.2147/NSA.S70782
work_keys_str_mv AT mollingjohanw comparativeperformanceofapanelofcommerciallyavailableantimicrobialnanocoatingsineurope
AT seezinkjacquesw comparativeperformanceofapanelofcommerciallyavailableantimicrobialnanocoatingsineurope
AT teunissenbirgitej comparativeperformanceofapanelofcommerciallyavailableantimicrobialnanocoatingsineurope
AT muijrerscheninhua comparativeperformanceofapanelofcommerciallyavailableantimicrobialnanocoatingsineurope
AT bormpaulja comparativeperformanceofapanelofcommerciallyavailableantimicrobialnanocoatingsineurope